A dose-effect study of the in vivo inhibitory effect of quinidine on sparteine oxidation in man.
about
Moclobemide treatment causes a substantial rise in the sparteine metabolic ratio. Danish University Antidepressant Group.An investigation of the interaction between halofantrine, CYP2D6 and CYP3A4: studies with human liver microsomes and heterologous enzyme expression systemsThe influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans.Inhibition of human cytochrome P450 2D6 (CYP2D6) by methadone.Physiologically based modelling of inhibition of metabolism and assessment of the relative potency of drug and metabolite: dextromethorphan vs. dextrorphan using quinidine inhibitionThe antitussive effect of dextromethorphan in relation to CYP2D6 activity.Inhibition of debrisoquine hydroxylation with quinidine in subjects with three or more functional CYP2D6 genesA clinical investigation of inhibitory effect of panobinostat on CYP2D6 substrate in patients with advanced cancer.Stereoselective and isozyme-selective drug interactions.In vitro forecasting of drugs that may interfere with codeine bioactivation.Pharmacokinetic profile of dextromethorphan hydrobromide in a syrup formulation in children and adolescents.Stereoselective inhibition of nortriptyline hydroxylation in man by quinidine.The effect of a low dose of quinidine on the disposition of flecainide in healthy volunteers.
P2860
Q24541294-8B6A438D-47A5-43ED-B086-F5BBEB247DDBQ34347566-C03D4023-BF4D-49AE-84C7-ED4B0CABF32FQ34400605-15F522AC-D184-4CDF-B8DA-FC5E0E676FDCQ34403471-25B9A9F8-B1F2-4B0A-95C3-9AF556C03A2CQ35825657-E06A3D02-2FDD-461A-AA62-17B680B1D158Q36053746-A7016505-3ACF-430C-8EA5-A3C08077112AQ36055046-F62B6658-6EFE-4AD2-994D-1C5380C31B2CQ39353969-402DD5E1-832A-403B-A805-EB7C682892EFQ40858967-DD6CE86A-E5FB-4DBB-AFF9-9479CD14B3BAQ41120633-65F11E94-AE4F-4B79-878F-B55BC990C943Q42672227-D9F7CA59-E2D2-449B-AA6F-17D793F2F1C4Q43483244-4D64A38B-796C-402B-B247-433E2EBBBC8BQ44953968-CDC9385C-2160-444B-8917-73CAF3890174
P2860
A dose-effect study of the in vivo inhibitory effect of quinidine on sparteine oxidation in man.
description
1990 nî lūn-bûn
@nan
1990 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի մարտին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
A dose-effect study of the in ...... on sparteine oxidation in man.
@ast
A dose-effect study of the in ...... on sparteine oxidation in man.
@en
A dose-effect study of the in ...... on sparteine oxidation in man.
@nl
type
label
A dose-effect study of the in ...... on sparteine oxidation in man.
@ast
A dose-effect study of the in ...... on sparteine oxidation in man.
@en
A dose-effect study of the in ...... on sparteine oxidation in man.
@nl
prefLabel
A dose-effect study of the in ...... on sparteine oxidation in man.
@ast
A dose-effect study of the in ...... on sparteine oxidation in man.
@en
A dose-effect study of the in ...... on sparteine oxidation in man.
@nl
P2093
P2860
P1476
A dose-effect study of the in ...... on sparteine oxidation in man.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.1990.TB03639.X
P407
P577
1990-03-01T00:00:00Z